Increasing prevalence of drug-resistant bacteria and incidence of hospital acquired infections are likely to drive the market for hospital acquired disease.
Need for advanced wound closure and wound management in chronic wounds underpins massive lucrative avenues for companies in wound irrigation systems market; growing applications in burn care
- Increasing regulatory approval of synthetic graft materials with high regenerative performance in dural repair enriching outcomes in neurosurgical interventions - R&D in animal tissue-derived